Centre hospitalier de l'Université de Montréal (CHUM)

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Centre hospitalier de l'Université de Montréal (CHUM) sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 3 currently recruiting 4 completed top decile by trial count

Centre hospitalier de l'Université de Montréal (CHUM): 10 sponsored US clinical trials, 3 recruiting.

Centre hospitalier de l'Université de Montréal (CHUM) sponsors 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Ultrasonography, with 1 trials.

Top-decile sponsor footprint

Centre hospitalier de l'Université de Montréal (CHUM) ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

10 total, page 1 of 1

RECRUITING

Development of a New Canadian Endourology Group Stent Symptom Score

NCT04909541
RECRUITING

Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study

NCT04973397
RECRUITING NA

Treatment of Brain AVMs (TOBAS) Study

NCT02098252
ACTIVE NOT RECRUITING Phase 2

Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer

NCT03759431
ACTIVE NOT RECRUITING NA

International Subarachnoid Aneurysm Trial II

NCT01668563
COMPLETED

Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury

NCT04095143
COMPLETED NA

Evaluation of Pain Before and After Removal of Non-obstructive Kidney Stones

NCT03657667
COMPLETED NA

DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial

NCT01943591
COMPLETED Phase 4

PRET: Patients Prone to Recurrence After Endovascular Treatment

NCT00626912
TERMINATED NA

Trial on Endovascular Aneurysm Management

NCT00537134

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Therapeutic Areas

Ultrasonography 1
Intracranial Hemorrhage Ruptured Aneurysm 1
Glottis Tumor 1
Cancer Neck 1
BAVM 1
AVM 1
Ruptured Brain Arteriovenous Malformation 1
Unruptured Brain Arteriovenous Malformation 1
Preoperative Care 1
Fluid Overload 1

What is open in the Centre hospitalier de l'Université de Montréal (CHUM) pipeline

3 recruiting of 10 indexed (30% open); 4 completed (40%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Ultrasonography (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Centre hospitalier de l'Université de Montréal (CHUM): open-pipeline peers nationwide

Peers matched on 10 registered trials and 30% open enrollment, not the therapeutic-area sidebar.

Centre hospitalier de l'Université de Montréal (CHUM) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 510152025 0%10%20%30%40% Total trials Recruiting share Centre hospitalier de l'Université de Montréal (CHUM)Adamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsChild TrendsJacques E. ChellyJason SperryMedtronic Cardiac Ablation Solutions
Centre hospitalier de l'Université de Montréal (CHUM) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Centre hospitalier de l'Université de Montréal (CHUM) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 30% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Centre hospitalier de l'Université de Montréal (CHUM) page

10 registered trials is a research-attention snapshot, not an endorsement of Centre hospitalier de l'Université de Montréal (CHUM) or any single study.

  • 3 of Centre hospitalier de l'Université de Montréal (CHUM)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Ultrasonography is the condition Centre hospitalier de l'Université de Montréal (CHUM) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Ultrasonography trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Centre hospitalier de l'Université de Montréal (CHUM) pipeline card: 10 registered trials from official public datasets.Report a data error.